As at 31 December 2023 and 2022
(€ Million) |
|
Notes |
|
2023 |
|
2022 |
||||
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
|
|
|
|
|
|
||||
Tangible assets |
|
|
5,253 |
|
4,340 |
|||||
Intangible assets |
|
|
790 |
|
755 |
|||||
Investment property |
|
|
|
9 |
|
9 |
||||
Right-of-use assets |
|
|
3,198 |
|
2,526 |
|||||
Biological assets |
|
|
|
8 |
|
6 |
||||
Investments in joint ventures and associates |
|
|
80 |
|
16 |
|||||
Other financial investments |
|
|
2 |
|
17 |
|||||
Trade debtors, accrued income and deferred costs |
|
|
59 |
|
58 |
|||||
Deferred tax assets |
|
|
230 |
|
201 |
|||||
Total non-current assets |
|
|
|
9,629 |
|
7,928 |
||||
Inventories |
|
|
1,790 |
|
1,493 |
|||||
Biological assets |
|
|
|
19 |
|
12 |
||||
Income tax receivable |
|
|
|
86 |
|
35 |
||||
Trade debtors, accrued income and deferred costs |
|
|
829 |
|
593 |
|||||
Derivative financial instruments |
|
|
6 |
|
2 |
|||||
Cash and cash equivalents |
|
|
1,938 |
|
1,781 |
|||||
Total current assets |
|
|
|
4,668 |
|
3,917 |
||||
Total assets |
|
|
|
14,297 |
|
11,845 |
||||
|
|
|
|
|
|
|
||||
Shareholders’ equity and liabilities |
|
|
|
|
|
|
||||
Share capital |
|
|
|
629 |
|
629 |
||||
Share premium |
|
|
|
22 |
|
22 |
||||
Own shares |
|
|
|
(6) |
|
(6) |
||||
Other reserves |
|
|
|
(110) |
|
(183) |
||||
Retained earnings |
|
|
2,278 |
|
1,869 |
|||||
|
|
|
|
2,814 |
|
2,331 |
||||
Non-controlling interests |
|
|
|
253 |
|
254 |
||||
Total shareholders’ equity |
|
|
|
3,066 |
|
2,585 |
||||
Borrowings |
|
|
280 |
|
238 |
|||||
Lease liabilities |
|
|
2,853 |
|
2,248 |
|||||
Trade creditors, accrued costs and deferred income |
|
|
4 |
|
4 |
|||||
Derivative financial instruments |
|
|
6 |
|
5 |
|||||
Employee benefits |
|
|
78 |
|
69 |
|||||
Provisions for risks and contingencies |
|
|
79 |
|
82 |
|||||
Deferred tax liabilities |
|
|
104 |
|
90 |
|||||
Total non-current liabilities |
|
|
|
3,404 |
|
2,735 |
||||
Borrowings |
|
|
485 |
|
232 |
|||||
Lease liabilities |
|
|
530 |
|
430 |
|||||
Trade creditors, accrued costs and deferred income |
|
|
6,705 |
|
5,799 |
|||||
Derivative financial instruments |
|
|
13 |
|
9 |
|||||
Income tax payable |
|
|
|
94 |
|
55 |
||||
Total current liabilities |
|
|
|
7,827 |
|
6,525 |
||||
Total shareholders’ equity and liabilities |
|
|
|
14,297 |
|
11,845 |
||||
|
||||||||||